Glaucoma is one of the leading causes of blindness worldwide, and as the proportion of
those over age 40 increases, so will the prevalence of glaucoma. The pathogenesis of …

Glaucoma is a neurodegenerative disease characterized by progressive loss of retinal
ganglion cells and their axons. Lowering of intraocular pressure (IOP) is currently the only …

Abstract Background This “Anti-Obesity Medications and Investigational Agents: An Obesity
Medicine Association Clinical Practice Statement 2022” is intended to provide clinicians an …

A number of pharmacological targets are exploited to modify the parameters in the
Goldmann equation and reduce the intraocular pressure (IOP). This strategy constitutes the …

Artificial intelligence techniques are now being applied in different medical solutions ranging
from disease screening to activity recognition and computer-aided diagnosis. The …

Glaucoma is a leading cause of irreversible blindness worldwide. While intraocular pressure
(IOP) presents a major risk factor, the underlying pathophysiology still remains largely …

Sex hormones are molecules produced by the gonads and to a small extent by the adrenal
gland, which not only determine the primary and secondary sexual characteristics of an …

Glaucoma, the leading cause of irreversible blindness worldwide, is a complex human
disease, with both genetic and environmental determinants. The availability of large-scale …

Background/aims Glucagon-like peptide-1 receptor (GLP-1R) agonists regulate blood
glucose and are commonly used to treat type 2 diabetes mellitus. Recent work showed that …

Purpose To investigate the association between cardiovascular disease and baseline
structural defects and disease progression in glaucoma. Design Prospective, longitudinal …